Akzo Nobel NV (LTS:0LND)
€ 60.08 -0.97 (-1.59%) Market Cap: 10.34 Bil Enterprise Value: 13.59 Bil PE Ratio: 16.71 PB Ratio: 2.12 GF Score: 70/100

Full Year 2025 Akzo Nobel NV Earnings Call Transcript

Feb 03, 2026 / 08:00AM GMT
Release Date Price: €56.65 (-3.06%)

Key Points

Positve
  • Akzo Nobel NV (AKZOF) achieved a full year adjusted EBITDA of EUR1.444 billion, within 1% of their initial constant currency guidance.
  • The company reported a 7% year-on-year increase in Q4 adjusted EBITDA on a comparable basis, with a 13% margin, up 70 basis points.
  • Operational efficiency led to net OpEx savings of EUR98 million, EUR28 million ahead of plan.
  • Free cash flow significantly increased to EUR606 million due to efficient working capital management.
  • The proposed merger with Axalta is expected to generate at least $600 million in cost synergies and enhance margins and cash generation.
Negative
  • Q4 volumes were down 2% year-on-year, with mixed performance across segments.
  • The Coatings segment experienced a 3% decline in volumes, primarily due to market pullback in North America.
  • The Packaging business faces a temporary pullback due to an industry technology shift and delayed product approvals, leading to expected market share loss in 2026.
  • Organic sales declined by 1% at the group level, with a reported revenue decline of 9% due to FX translation and divestments.
  • The company does not anticipate a material recovery across end markets in 2026, with a weak first half expected.
Jan Willem Enhus
Akzo Nobel NV - Head of Investor Relations

Good morning, everyone, and welcome to Akzo Nobel's investor update for the fourth quarter and full year 2025. I'm Jan Willem Enhus, Head of Investor Relations.

Today, our CEO, Greg Poux-Guillaume; and CFO, Maarten de Vries, will take you through our results. We'll refer to the presentation, which you can follow by webcast or download from our website at akzonobel.com. A replay of the webcast will also be made available following the event. There will be a Q&A session after the presentation. For additional information, please contact our Investor Relations team.

Before we start, a reminder of our forward-looking statements disclaimer on slide 2. Please note, this also applies to the conference call and answers to your questions.

I will now hand over to Greg, who will start on slide 3 of the presentation.

Gregoire Poux;Guillaume
Akzo Nobel NV - Chairman of the Management Board, Chief Executive Officer, Executive Committee

Thanks, Jan Willem. Good

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot